| CEBRX | MEDGX | CEBRX / MEDGX | |
| Total Expense Ratio | 0.73 | 0.82 | 89% |
| Annual Report Gross Expense Ratio | 0.73 | 0.83 | 88% |
| Fund Existence | 14 years | 18 years | - |
| Gain YTD | 2.837 | 2.865 | 99% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | N/A | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 370M | 7.64B | 5% |
| Annual Yield % from dividends | 5.13 | 5.41 | 95% |
| Returns for 1 year | 10.21 | 10.31 | 99% |
| Returns for 3 years | 32.46 | 32.33 | 100% |
| Returns for 5 years | 13.78 | 15.05 | 92% |
| Returns for 10 years | 42.70 | 45.65 | 94% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| MLVTX | 18.68 | 0.23 | +1.25% |
| MFS Low Volatility Equity R6 | |||
| DISCX | 22.13 | 0.20 | +0.91% |
| BNY Mellon International Stock Fund C | |||
| AUEIX | 18.79 | 0.05 | +0.27% |
| AQR Large Cap Defensive Style I | |||
| WCMRX | 27.84 | -0.08 | -0.29% |
| WCM Focused International Growth Inv | |||
| CZMGX | 22.08 | -0.23 | -1.03% |
| Columbia Integrated Large Cap Gr II Inst | |||